Zurich Cantonal Bank’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $531K | Sell |
3,864
-1,878
| -33% | -$258K | ﹤0.01% | 1628 |
|
|
2025
Q1 | $1.04M | Sell |
5,742
-312
| -5% | -$56.3K | ﹤0.01% | 1140 |
|
|
2024
Q4 | $948K | Buy |
6,054
+1,440
| +31% | +$226K | ﹤0.01% | 1204 |
|
|
2024
Q3 | $840K | Buy |
4,614
+153
| +3% | +$27.9K | ﹤0.01% | 1219 |
|
|
2024
Q2 | $819K | Buy |
4,461
+169
| +4% | +$31K | ﹤0.01% | 1176 |
|
|
2024
Q1 | $764K | Sell |
4,292
-173
| -4% | -$30.8K | ﹤0.01% | 1212 |
|
|
2023
Q4 | $554K | Sell |
4,465
-22
| -0.5% | -$2.73K | ﹤0.01% | 1437 |
|
|
2023
Q3 | $520K | Buy |
4,487
+452
| +11% | +$52.4K | ﹤0.01% | 1376 |
|
|
2023
Q2 | $474K | Buy |
4,035
+1,298
| +47% | +$152K | ﹤0.01% | 1386 |
|
|
2023
Q1 | $219K | Sell |
2,737
-520
| -16% | -$41.6K | ﹤0.01% | 1809 |
|
|
2022
Q4 | $258K | Sell |
3,257
-832
| -20% | -$65.9K | ﹤0.01% | 1671 |
|
|
2022
Q3 | $285K | Hold |
4,089
| – | – | ﹤0.01% | 1543 |
|
|
2022
Q2 | $268K | Sell |
4,089
-36
| -0.9% | -$2.36K | ﹤0.01% | 1619 |
|
|
2022
Q1 | $274K | Sell |
4,125
-430
| -9% | -$28.6K | ﹤0.01% | 1701 |
|
|
2021
Q4 | $319K | Buy |
4,555
+3,603
| +378% | +$252K | ﹤0.01% | 1772 |
|
|
2021
Q3 | $50K | Buy |
952
+11
| +1% | +$578 | ﹤0.01% | 2613 |
|
|
2021
Q2 | $64K | Buy |
941
+39
| +4% | +$2.65K | ﹤0.01% | 2382 |
|
|
2021
Q1 | $69K | Buy |
+902
| New | +$69K | ﹤0.01% | 2299 |
|